These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37743335)

  • 1. [Mesenchymal and Non-meningothelial Tumors Involving the Central Nervous System].
    Oya S; Murakami C
    No Shinkei Geka; 2023 Sep; 51(5):837-844. PubMed ID: 37743335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal non-meningothelial tumors of the central nervous system: a literature review and diagnostic update of novelties and emerging entities.
    Tauziède-Espariat A; Hasty L; Métais A; Varlet P
    Acta Neuropathol Commun; 2023 Feb; 11(1):22. PubMed ID: 36737790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Non-Meningothelial Tumors of the CNS: Evolving Molecular Landscape and Implications for Neuroradiologists.
    Soni N; Ora M; Szekeres D; Bathla G; Desai A; Gupta V; Singhal A; Agarwal A
    AJNR Am J Neuroradiol; 2024 Sep; ():. PubMed ID: 39349307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the spectrum of "mesenchymal" tumors of the central nervous system.
    Pizzimenti C; Gianno F; Gessi M
    Pathologica; 2022 Dec; 114(6):455-464. PubMed ID: 36534424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial mesenchymal tumor with (novel) COX14::PTEN rearrangement.
    d'Amati A; Gianno F; Scuccimarri L; Lastilla M; Messina R; Signorelli F; Zimatore DS; Barresi S; Miele E; Alaggio R; Rossi S; Maiorano E; Ingravallo G; Giangaspero F; Antonelli M
    Acta Neuropathol Commun; 2023 Jun; 11(1):95. PubMed ID: 37312212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system tumors of uncertain differentiation.
    A Jacobo J
    World Neurosurg X; 2024 Apr; 22():100349. PubMed ID: 38455248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some CNS sarcomas seen: A 22-year series.
    Kleinschmidt-DeMasters BK; Gilani A
    Clin Neuropathol; 2023; 42(2):54-65. PubMed ID: 36708209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sarcomas of the central nervous systems. Clinical observations].
    Ryzhova MV; Galstyan SA; Telysheva EN; Shaikhaev EG; Snigireva GP; Gorelyshev SK; Kadyrov SU; Shimanskiy VN; Shugay SV; Panina TN
    Arkh Patol; 2022; 84(3):40-47. PubMed ID: 35639842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomas.
    Sloan EA; Gupta R; Koelsche C; Chiang J; Villanueva-Meyer JE; Alexandrescu S; Eschbacher JM; Wang W; Mafra M; Ud Din N; Carr-Boyd E; Watson M; Punsoni M; Oviedo A; Gilani A; Kleinschmidt-DeMasters BK; Coss DJ; Lopes MB; Reddy A; Mueller S; Cho SJ; Horvai AE; Lee JC; Pekmezci M; Tihan T; Bollen AW; Rodriguez FJ; Ellison DW; Perry A; von Deimling A; Chang SM; Berger MS; Solomon DA
    Brain Pathol; 2022 Jul; 32(4):e13037. PubMed ID: 34821426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes.
    Tauziède-Espariat A; Pierron G; Guillemot D; Sievers P; Cazals-Hatem D; Faillot T; Roux A; Benzakoun J; Bockel S; Weinbreck N; Hasty L; Lechapt E; Chrétien F; Varlet P
    Acta Neuropathol Commun; 2021 Oct; 9(1):174. PubMed ID: 34715942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant.
    Wolf T; Coca AH; Weingertner N; Chenard MP; Meurgey A; Reita D; Pencreach E; Varlet P; Entz-Werlé N; Lhermitte B
    Virchows Arch; 2023 Feb; 482(2):431-435. PubMed ID: 36307659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patients.
    Diaz Coronado RY; Mynarek M; Koelsche C; Mora Alferez P; Casavilca Zambrano S; Wachtel Aptowitzer A; Sahm F; von Deimling A; Schüller U; Spohn M; Sturm D; Pfister SM; Morales La Madrid A; Sernaque Quintana R; Sarria Bardales G; Negreiros Chinchihuara T; Ojeda Medina L; Garcia-Corrochano Medina P; Campos Sanchez DA; Ponce Farfan J; Rutkowski S; Garcia Leon JL
    Cancer; 2022 Feb; 128(4):697-707. PubMed ID: 34674226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.
    Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO
    Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICER1-associated central nervous system sarcoma with neural lineage differentiation: a case report.
    Yao K; Duan Z; Feng J; Yan C; Qi X
    Diagn Pathol; 2022 Sep; 17(1):72. PubMed ID: 36153506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.
    Tauziède-Espariat A; Sievers P; Larousserie F; Benzakoun J; Guillemot D; Pierron G; Duchesne M; Uro-Coste E; Roux A; Vasiljevic A; Fenouil T; Meyronet D; Mokhtari K; Polivka M; Rousseau A; Bost-Bezeaud F; Akoury S; Pallud J; Benevello C; Hasty L; Gareton A; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Puget S; Sahm F; Varlet P;
    Brain Pathol; 2022 Jan; 32(1):e13010. PubMed ID: 34314078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of pediatric soft tissue tumors with review of conventional MRI appearance-part 1: tumor-like lesions, adipocytic tumors, fibroblastic and myofibroblastic tumors, and perivascular tumors.
    Porrino J; Al-Dasuqi K; Irshaid L; Wang A; Kani K; Haims A; Maloney E
    Skeletal Radiol; 2022 Mar; 51(3):477-504. PubMed ID: 34191084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system sarcoma with ATXN1::DUX4 fusion expands the concept of CIC-rearranged sarcoma.
    Satomi K; Ohno M; Kubo T; Honda-Kitahara M; Matsushita Y; Ichimura K; Narita Y; Ichikawa H; Yoshida A
    Genes Chromosomes Cancer; 2022 Nov; 61(11):683-688. PubMed ID: 35715887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
    Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
    Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal, non-meningothelial tumors of the central nervous system.
    Jellinger K; Paulus W
    Brain Pathol; 1991 Jan; 1(2):79-87. PubMed ID: 1669699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.